Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q3)Dec 31, 2025 | (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1,425.44%-1.55M | -139.18%-254.81K | 68.67%-106.46K | -65.68%-710.14K | 10.49%-162.3K | 23.90%-101.49K | -542.93%-106.53K | -248.99%-339.82K | 43.90%-428.63K | -2,727.36%-181.31K |
| Net income from continuing operations | -740.02%-1.41M | -12.43%-277.65K | 20.27%-177.36K | -27.65%-863.79K | 30.32%-226.66K | -55.55%-167.73K | -141.77%-246.95K | -57.30%-222.45K | 31.69%-676.67K | -43.24%-325.28K |
| Depreciation and amortization | -16.36%6.72K | 58.54%14.11K | 7.46%9.18K | 3.29%33.83K | 2.26%8.36K | -1.73%8.03K | 8.86%8.9K | 3.74%8.54K | -8.35%32.75K | -8.83%8.17K |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Unrealized gains and losses of investment securities | 74.88%-4.96K | -136.94%-9.05K | 32.93%15.84K | 15.62%24.37K | 467.46%7.72K | 3.95%-19.76K | -15.56%24.49K | -19.21%11.91K | -72.93%21.08K | 91.55%-2.1K |
| Remuneration paid in stock | 687.74%247.3K | -74.72%10.2K | -74.39%12.24K | 274.59%142.41K | -62.16%22.9K | --31.39K | 279.31%40.35K | --47.78K | 330.42%38.02K | --60.52K |
| Deferred tax | --0 | --0 | --0 | 297.13%49.87K | 304.85%51.83K | --0 | ---620 | ---1.33K | 70.19%-25.3K | ---25.3K |
| Other non cashItems | -27,650.50%-109.65K | 1,743.18%723 | 98.94%-343 | -349.61%-44.44K | -19.80%-12.49K | -28.16%398 | -108.89%-44 | -6,247.54%-32.31K | -3,655.76%-9.89K | -23,266.67%-10.43K |
| Change In working capital | -603.08%-232.31K | -89.80%6.87K | 122.37%34K | -127.38%-52.39K | -112.34%-13.96K | 437.31%46.18K | -4.34%67.34K | -804.29%-151.96K | 52.75%191.38K | -27.28%113.1K |
| -Change in receivables | -961.25%-65.35K | 1,105.25%128.31K | 50.98%-4.57K | 60.31%-12.04K | 22.77%-7.22K | 53.63%-6.16K | 371.93%10.65K | -144.87%-9.32K | -137.14%-30.34K | -108.56%-9.34K |
| -Change in prepaid assets | -964.87%-155.31K | -376.21%-108.99K | 200.68%18.63K | 92.62%-2.95K | -542.96%-41.86K | 134.41%17.96K | 404.19%39.46K | -267.43%-18.5K | -194.25%-39.94K | 1,005.17%9.45K |
| -Change in payables and accrued expense | -133.88%-11.65K | -172.25%-12.46K | 116.06%19.94K | -114.29%-37.4K | -68.92%35.12K | -33.60%34.38K | -74.07%17.24K | -508.14%-124.14K | 21,383.17%261.67K | 138.10%112.99K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1,425.44%-1.55M | -139.18%-254.81K | 68.67%-106.46K | -65.68%-710.14K | 10.49%-162.3K | 23.90%-101.49K | -542.93%-106.53K | -248.99%-339.82K | 43.90%-428.63K | -2,727.36%-181.31K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -639.09%-1.19K | -194.70%-20.61K | 23.15%-6.78K | 0 | 0 | 106.27%220 | -645.21%-7K | -261.29%-8.82K | 0 |
| Net PPE purchase and sale | --0 | --0 | --0 | -40.13%-14.4K | --0 | --0 | --0 | ---14.4K | 78.03%-10.27K | --0 |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Interest received (cash flow from investment activities) | --0 | -639.09%-1.19K | -37.61%1.19K | 45.57%2.12K | --0 | --0 | 26.44%220 | 48.17%1.9K | 3.11%1.46K | --0 |
| Net other investing changes | --0 | --0 | -496.36%-21.8K | --5.5K | --0 | --0 | --0 | --5.5K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -639.09%-1.19K | -194.70%-20.61K | 23.15%-6.78K | --0 | --0 | 106.27%220 | -645.21%-7K | -261.29%-8.82K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 23,666.76%1.5M | 4,036.69%653.02K | -100.96%-6.54K | 70.25%648.35K | -104.33%-6.54K | -102.63%-6.36K | -174.27%-16.59K | 11,307.56%677.83K | 1,622.65%380.82K | 2,597.26%151.03K |
| Net issuance payments of debt | -4.47%-6.64K | -4.13%-6.53K | -4.18%-6.54K | -3.87%-25.44K | -4.18%-6.54K | -3.87%-6.36K | -3.72%-6.27K | -3.72%-6.27K | -3.25%-24.49K | -3.72%-6.27K |
| Net common stock issuance | --1.53M | --300K | --0 | 70.00%722.5K | --0 | --0 | --0 | --722.5K | --425K | --170K |
| Net other financing activities | ---360.75K | ---- | ---- | -147.34%-48.71K | --0 | --0 | ---10.32K | ---38.39K | -1,426.59%-19.69K | ---12.69K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 23,666.76%1.5M | 4,036.69%653.02K | -100.96%-6.54K | 70.25%648.35K | -104.33%-6.54K | -102.63%-6.36K | -174.27%-16.59K | 11,307.56%677.83K | 1,622.65%380.82K | 2,597.26%151.03K |
| Net cash flow | ||||||||||
| Beginning cash position | -2.85%451.76K | -90.69%54.74K | -26.69%188.35K | -18.06%256.91K | 24.37%357.18K | 151.00%465.03K | 178.11%587.93K | -18.06%256.91K | -71.42%313.54K | 0.87%287.19K |
| Current changes in cash | 54.32%-49.26K | 423.05%397.03K | -140.36%-133.61K | -21.09%-68.57K | -457.58%-168.83K | -205.81%-107.85K | -370.36%-122.9K | 424.08%331.02K | 92.77%-56.63K | -205.03%-30.28K |
| End cash Position | 12.69%402.5K | -2.85%451.76K | -90.69%54.74K | -26.69%188.35K | -26.69%188.35K | 24.37%357.18K | 151.00%465.03K | 178.11%587.93K | -18.06%256.91K | -18.06%256.91K |
| Free cash from | -1,425.44%-1.55M | -139.18%-254.81K | 69.95%-106.46K | -65.08%-724.54K | 10.49%-162.3K | 27.49%-101.49K | -425.96%-106.53K | -263.77%-354.22K | 45.87%-438.9K | -2,727.36%-181.31K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.